Loading...

NSPR INSPIREMD INC Operational Disruptions 8-K Filing

NSPR

NSPR

INSPIREMD INC

(NSPR)

2023 8-K

Show Summary

Summary

Financial Statements

Equity Offerings

New Product Launches

Pre-Market Approval

Pre-Market Approval

Financial Statements

Financial Results

Clinical Trial Update

Board Appointment

Earnings Announcement

New Headquarters

Inducement Plan

FDA Approval Application

Earnings Reports

Investor Presentation

Annual Meeting Voting Results

Equity Distribution Agreement

Earnings Reports

Amendment of Employment Agr...

Earnings Reports

CE Mark Recertification

Patent Issuance

Strategic Agreement

Earnings Reports

Clinical Trial Results

Reappointment of Officers

Earnings Reports

Completion of Enrollment in...

Investor Presentation

Earnings Reports

Securities Purchase Agreement

Earnings Reports

Promotion of Andrea Tommaso...

External Links:

InspireMD presents positive 30-day follow-up results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) clinical trial at VIVA23.

AI Assistant

INSPIREMD INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.